The Southeastern Acute Kidney Injury (SEAK) Alliance for the COPE-AKI Consortium

COPE-AKI 联盟东南部急性肾损伤 (SEAK) 联盟

基本信息

项目摘要

Acute kidney injury (AKI) is an enormous public health problem that affects up to 20% of hospitalized patients, is strongly associated with morbidity and mortality, and carries a high financial toll. Nowhere is this more apparent than in the Southeastern US, which is disproportionately affected by kidney disease and its complications. AKI is an important risk factor for chronic kidney disease (CKD), cardiovascular disease, poor health-related quality of life (HRQoL), rehospitalizations, and death after hospital discharge. Improving the quality of care following hospitalization has been recognized by the National Institute of Diabetes and Digestive and Kidney Diseases and other stakeholders as a critical opportunity to reduce the risk for these long-term complications. Despite this emphasis, care of AKI survivors is often poor and fragmented, and patients face both systemic and individual-level barriers to optimal care. These include poor access to nephrology-specific care elements such as monitoring of kidney function for recovery or recurrent AKI, risk factor identification and modification for kidney disease progression, medication reconciliation and nephrotoxin avoidance, use of kidney and cardioprotective medications, and appropriate patient and caregiver education. In addition, many patients also experience poor quality of life and other barriers to care, including a heavy symptom burden and fatigue, limited mobility, reduced access to transportation or ability to miss work that can further limit engagement in care. This application will perform a randomized clinical trial designed to examine whether two interventions delivered remotely via telehealth can overcome these barriers to reduce clinical complications and improve health-related quality of life among patients discharged from the hospital with moderate to severe AKI. Two interventions will be tested over a 90-day period following hospital discharge. The first intervention is a ‘post-hospitalization AKI care bundle’ designed to optimize care that includes monitoring of kidney health, medication safety review and reconciliation, patient and caregiver education, and identification of modifiable risk factors for further loss of kidney function. The second intervention is cognitive-behavioral based physical therapy (CBPT), a novel home-based intervention that couples self-directed exercise with cognitive-behavioral strategies that can reduce patient’s perception of symptoms and improve engagement and functional status. We will test the ability of these interventions to improve clinical outcomes after AKI such as rehospitalizations/emergency room visits, recurrent AKI, death, and kidney function at 90 days. We will also evaluate health-related quality of life and symptom burden. Patients will be followed for up to 12 months after enrollment to examine the longer-term impact of these interventions. The study will be performed at Vanderbilt University Medical Center (PI Siew) and University of Alabama Birmingham (MPI Gutierrez), two academic medical centers in the Southeast with diverse patient populations and robust infrastructures to support the proposed work and objectives of the Caring for Outpatients after Acute Kidney Injury (COPE-AKI) Consortium.
急性肾损伤(AKI)是一个巨大的公共卫生问题,影响了多达20%的住院患者,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Orlando M Gutierrez其他文献

Orlando M Gutierrez的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Orlando M Gutierrez', 18)}}的其他基金

Deep South KUH Premier Research and Inter-disciplinary Mentored Education (PRIME) Admin Core
深南 KUH 顶级研究和跨学科指导教育 (PRIME) 管理核心
  • 批准号:
    10724927
  • 财政年份:
    2023
  • 资助金额:
    $ 66.67万
  • 项目类别:
Dimensions of Kidney Tubule Health and Atherosclerotic Cardiovascular Disease and Heart Failure in Middle-Aged and Older Adults
中老年人肾小管健康状况与动脉粥样硬化性心血管疾病和心力衰竭的关系
  • 批准号:
    10588310
  • 财政年份:
    2022
  • 资助金额:
    $ 66.67万
  • 项目类别:
Kidney Tubule Dysfunction and Future Risk of Acute Kidney Injury
肾小管功能障碍和未来急性肾损伤的风险
  • 批准号:
    10449922
  • 财政年份:
    2021
  • 资助金额:
    $ 66.67万
  • 项目类别:
Kidney Tubule Dysfunction and Future Risk of Acute Kidney Injury
肾小管功能障碍和未来急性肾损伤的风险
  • 批准号:
    10214194
  • 财政年份:
    2021
  • 资助金额:
    $ 66.67万
  • 项目类别:
Investigator Development Core
研究者开发核心
  • 批准号:
    10494286
  • 财政年份:
    2021
  • 资助金额:
    $ 66.67万
  • 项目类别:
Investigator Development Core
研究者开发核心
  • 批准号:
    10676261
  • 财政年份:
    2021
  • 资助金额:
    $ 66.67万
  • 项目类别:
Investigator Development Core
研究者开发核心
  • 批准号:
    10437092
  • 财政年份:
    2021
  • 资助金额:
    $ 66.67万
  • 项目类别:
Kidney Tubule Dysfunction and Future Risk of Acute Kidney Injury
肾小管功能障碍和未来急性肾损伤的风险
  • 批准号:
    10610328
  • 财政年份:
    2021
  • 资助金额:
    $ 66.67万
  • 项目类别:
Kidney Tubule Dysfunction and Future Risk of Acute Kidney Injury
肾小管功能障碍和未来急性肾损伤的风险
  • 批准号:
    10376834
  • 财政年份:
    2021
  • 资助金额:
    $ 66.67万
  • 项目类别:
Timing of sodium intake and nocturnal sodium excretion and blood pressure in obese African Americans
肥胖非裔美国人的钠摄入时间和夜间钠排泄以及血压
  • 批准号:
    10215613
  • 财政年份:
    2019
  • 资助金额:
    $ 66.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了